SCHEMBL3427110

SCHEMBL3427110

Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCc2ccccc2C(F)(F)F)cn1

nearest known ligand 0.70

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 16/20 0.70
CYP2C9 P11712 12/20 0.70
MAPK11 Q15759 3/20 0.70
BUB1 O43683 1/20 0.70
PRKACG P22612 1/20 0.70
MAPKAPK2 P49137 1/20 0.70
ACSL5 Q9ULC5 1/20 0.70
STK24 Q9Y6E0 1/20 0.70
ROCK2 O75116 2/20 0.46
ROCK1 Q13464 1/20 0.45
MAPK13 O15264 1/20 0.45
EPHX2 P34913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3533718 0.92 MAPK14 (0.70) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL3412151 0.91 MAPK14 (0.74) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL3538654 0.90 MAPK14 (0.68) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL3425121 0.90 MAPK14 (0.73) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL3535883 0.90 MAPK14 (0.73) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL27598485 0.89 MAPK14 (0.54) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL3407001 0.88 MAPK14 (0.70) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL30335917 0.88 MAPK14 (0.70) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL3406811 0.87 MAPK14 (0.71) MAPK14CYP2C9MAPK11BUB1PRKACG
SCHEMBL3539283 0.87 MAPK14 (0.70) MAPK14CYP2C9MAPK11BUB1PRKACG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709506-B2 Nicotinamide derivatives useful as p38 inhibitors GLAXOSMITHKLINE LLC (US) 2010-05-04 US disclosed
US-7125898-B2 Nicotinamide derivatives useful as p38 inhibitors. SMITHKLINE BEECHAM CORPORATION (US) 2006-10-24 US disclosed